LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Zacharon Pharmaceuticals

New class of small molecule glycan-targeted drugs to address substantial unmet needs, including: lysosomal storage, oncology, inflammation, and other....

Get a Demo and See the Full Profile

Get a demo today to see profiles of Zacharon Pharmaceuticals plus 6131 other startups.

Learn More About Zacharon Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More